Oxidized mitochondrial DNA induces gasdermin D oligomerization in systemic lupus erythematosus.
Naijun MiaoZhuning WangQinlan WangHongyan XieNinghao YangYanzhe WangJin WangHaixia KangWenjuan BaiYuanyuan WangRui HeKepeng YanYang WangQiong-Yi HuZhaoyuan LiuFubin LiFeng WangFlorent GinhouxXiaoling ZhangJianyong YinLimin LuJing WangPublished in: Nature communications (2023)
Although extracellular DNA is known to form immune complexes (ICs) with autoantibodies in systemic lupus erythematosus (SLE), the mechanisms leading to the release of DNA from cells remain poorly characterized. Here, we show that the pore-forming protein, gasdermin D (GSDMD), is required for nuclear DNA and mitochondrial DNA (mtDNA) release from neutrophils and lytic cell death following ex vivo stimulation with serum from patients with SLE and IFN-γ. Mechanistically, the activation of FcγR downregulated Serpinb1 following ex vivo stimulation with serum from patients with SLE, leading to spontaneous activation of both caspase-1/caspase-11 and cleavage of GSDMD into GSDMD-N. Furthermore, mtDNA oxidization promoted GSDMD-N oligomerization and cell death. In addition, GSDMD, but not peptidyl arginine deiminase 4 is necessary for extracellular mtDNA release from low-density granulocytes from SLE patients or healthy human neutrophils following incubation with ICs. Using the pristane-induced lupus model, we show that disease severity is significantly reduced in mice with neutrophil-specific Gsdmd deficiency or following treatment with the GSDMD inhibitor, disulfiram. Altogether, our study highlights an important role for oxidized mtDNA in inducing GSDMD oligomerization and pore formation. These findings also suggest that GSDMD might represent a possible therapeutic target in SLE.
Keyphrases
- mitochondrial dna
- systemic lupus erythematosus
- copy number
- cell death
- disease activity
- cell cycle arrest
- induced apoptosis
- circulating tumor
- single molecule
- cell free
- end stage renal disease
- rheumatoid arthritis
- endothelial cells
- metabolic syndrome
- newly diagnosed
- genome wide
- small molecule
- nitric oxide
- oxidative stress
- diabetic rats
- ejection fraction
- cell proliferation
- chronic kidney disease
- circulating tumor cells
- smoking cessation
- binding protein
- nucleic acid
- replacement therapy